Home » Authors » Kim Coghill

Kim Coghill

Articles

ARTICLES

Push For Public Posting Of Clinical Trial Data Continues

Sep. 10, 2004

Push For Public Posting Of Clinical Trial Data Continues

Sep. 10, 2004

Encysive Brings In $30.8M, Presents Thelin Data At ERS

Sep. 9, 2004

Encysive Brings In $30.8M, Presents Thelin Data At ERS

Sep. 9, 2004

States Angling To Control Reimportation, Stem Cells

Sep. 7, 2004

States Angling To Control Reimportation, Stem Cells

Sep. 7, 2004

Achillion Gets $10.4M As Part Of Series D, Names New CEO

Sep. 3, 2004

Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)

Achillion Gets $10.4M As Part Of Series D, Names New CEO

Sep. 3, 2004

Achillion Pharmaceuticals Inc. on Thursday closed a $10.4 million financing and announced the appointment of Michael Kishbauch as president and CEO. (BioWorld Today)

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Sep. 2, 2004

MDS Paying Applied Biosystems $40M For MALDI Product Line IP

Sep. 2, 2004

View All Articles by Kim Coghill

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...